MyClyns

1
(No Transcript)
2
MyClyns
3
What Is MyClyns

• MyClyns is the only convenient (pen-like
  device), non-alcohol, first response spray
  providing immediate personal protection against a
  potentially harmful exposure that is safe to use
  on your eyes, ears, mouth, nose wounds.
• MyClyns contains a fast-acting solution with
  germ-killing action that is safe to use on all
  mucous membranes.

4
What Is MyClyns (Continued)

• Independent laboratory tests show that the
  solution in MyClyns demonstrates a 99.99
  reduction in MRSA and many other germs on
  contact, and a 99.99 reduction in Hepatitis C
  after thirty seconds. MyClyns has also
  demonstrated virucidal activity against HIV-1 and
  Herpes Simplex Virus type 1 in independent
  laboratory tests.
• MyClyns protects personnel immediately after
  exposure to harmful pathogens allowing them to
  continue to attend to the situation at hand.

5
Who Should Use MyClyns
6
How does MyClyns Work

• MyClyns Personal Spray is the only non-alcohol
  option you can keep in your pocket and spray
  directly in your face. It is ready to use in the
  field when you need effective protection right
  away.MyClyns is intended to be used following
  exposure to bodily fluids or other materials
  potentially containing pathogens including
• Blood
• Saliva
• Vomit
• Urine
• Faeces
• Other bodily fluids

7
How To Use MyClyns
8
MyClyns Vs Alternatives
9
MyClyns as a Hand Sanitiser

• Not recommended for use as a routine hand
  sanitiser.
• MyClyns does not replace other standard
  post-exposure procedures. You should utilise
  post-exposure protocols as required.

10
Why Use MyClyns
11
Why Use MyClyns (continued)

• Imperial College London
• Mucocutaneous transmission occurs through broken
  or apparently intact skin or through the mucous
  membranes of the eyes, nose or mouth.The chances
  of infection with HIV, Hepatitis B or Hepatitis C
  viruses following mucocutaneous exposure to
  infected blood are generally much lower compared
  to those associated with needlestick injuries.
• Of the 106 definite cases of HIV transmission,
• 8 were caused by mucocutaneous exposure to
  infected.
• A further two cases involved both percutaneous
  and mucocutaneous exposures.
• There are also no documented cases of
  seroconversion following mucocutaneous splashes
  with blood contaminated with Hepatitis B virus.
  Despite these lower transmission rates following
  mucocutaneous exposure the fact remains that
  these agents are potentially infectious via this
  route and the risks should not be underestimated.
• http//www3.imperial.ac.uk/safety/guidanceandadvic
  e/biosafety/bloodborneinfections
• First issued November 2006

12
MyClyns and Legislation
13
Controlling the Risks

• MyClyns can assist organisations in meeting COSHH
  guidelines for minimising the risks. The methods
  chosen to control the risks identified by the
  risk assessmentshould follow the hierarchical
  approach which is common to both MHSWR andCOSHH.
  The hierarchy reflects the fact that eliminating
  and controlling risk byusing physical
  engineering controls and safeguards is more
  dependable thanrelying solely on systems of
  work
• controlling risks at source by using
  engineering controls and giving collective
  protective measures priority, eg using a
  microbiological safety cabinet when work could
  create an infectious aerosol, or using needle
  safety devices to prevent and control needlestick
  injuries and
• minimising risks by designing suitable systems
  of working eg having an effective hand hygiene
  policy in place in laboratory or healthcare
  settings. This option also includes the use of
  personal protective clothing and equipment (PPE),
  but PPE should only be used as a last resort
  after consideringelimination or tackling at
  source.

14
My Clyns and BBV

• What are blood-borne viruses (BBVs)?
• BBVs are viruses that some people carry in
  their blood and which may cause severe disease in
  certain people and few or no symptoms in others.
  The virus can spread to another person, whether
  the carrier of the virus is ill or not.
• The main BBVs of concern are
• hepatitis B virus (HBV), hepatitis C virus and
  hepatitis D virus, which all cause hepatitis, a
  disease of the liver
• human immunodeficiency virus (HIV) which causes
  acquired immune deficiency syndrome (AIDS),
  affecting the immune system of the body.
• These viruses can also be found in body
  fluids other than blood, for example, semen,
  vaginal secretions and breast milk. Other body
  fluids or materials such as urine, faeces,
  saliva, sputum, sweat, tears and vomit carry a
  minimal risk of BBV infection, unless they are
  contaminated with blood. Care should still be
  taken as the presence of blood is not always
  obvious.

15
My Clyns and BBV

• If you are contaminated with blood or other body
  fluids, take the following action without delay
• wash splashes off your skin with soap and running
  water
• if your skin is broken, encourage the wound to
  bleed, do not suck the wound rinse thoroughly
  under running water
• wash out splashes in your eyes using tap water or
  an eye wash bottle, and your nose or mouth with
  plenty of tap water do not swallow the water
• record the source of contamination
• report the incident to your supervisor, line
  manager or health and safety adviser and your
  occupational health department or medical adviser
  if there is one.

• MyClyns can give enhanced protection after
  possible infection with a BBV.
• It can be incorporated into the following HSE
  Action Plan by giving immediate protection
• Prior
• to following the guidelines
• And After

16
Final Thoughts

• Infection is an occupational health risk for
  health professionals, the most serious threat
  being exposure to blood and body fluids leading
  to infection with blood borne viruses,e.g.HIV,
  Hepatitis B.
• Staff that have an accidental inoculation injury
  have a 30 risk of developing Hepatitis B when
  the source patient is infected (DOH 1998).
• Cost
• Estimated at 1 billion annually (NAO 2000).
• Cost
• FinancialCosts almost 1 billion pounds annually.
• Resources blocked
• Litigation
• Loss of life.

17
Sources of Information

• http//www3.imperial.ac.uk/safety/guidanceandadvic
  e/biosafety/bloodborneinfections - First issued
  November 2006
• The chronic health effects of exposure to
  biological agents A systematic literature review
  HSE - Prepared by the Public Health Laboratory
  Service in Wales and theWelsh Combined Centres
  for Public Health (Wales) for the Health and
  Safety Executive 2002
• Blood-borne viruses in the workplace Guidance for
  employers and employees HSE Guidance -
  www.hse.gov.uk/pubns/indg342.pdf - First
  published 07/01.
• Biological agents Managing the risks in
  laboratories and healthcare premises - Advisory
  Committee on Dangerous Pathogens HSE - First
  published 05/05